Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-009960
Filing Date
2015-05-13
Accepted
2015-05-13 16:30:43
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sphs20150331_10q.htm 10-Q 1073055
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13553
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14779
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8143
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8127
  Complete submission text file 0001437749-15-009960.txt   5652764

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS sphs-20150331.xml EX-101.INS 878662
7 EXHIBIT 101.SCH sphs-20150331.xsd EX-101.SCH 42586
8 EXHIBIT 101.CAL sphs-20150331_cal.xml EX-101.CAL 31957
9 EXHIBIT 101.DEF sphs-20150331_def.xml EX-101.DEF 170648
10 EXHIBIT 101.LAB sphs-20150331_lab.xml EX-101.LAB 231253
11 EXHIBIT 101.PRE sphs-20150331_pre.xml EX-101.PRE 173580
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 15858816
SIC: 2834 Pharmaceutical Preparations